By G HossainPosted on July 9, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs GSK and Alector first partnered in 2021 to advance two antibodies for neurodegenerative diseases. Both assets have since failed to show significant clinical benefit. GSK abandons Alector after back-to-back neuro stumbles Post navigation IRS eases filing of protective COVID refund claims by July 10Psychedelics surge again as Compass, Definium provide more clinical validation
